| Balance Sheets | 2025-08-31 | |||
|---|---|---|---|---|
| Cash and cash equivalents | 223 | |||
| Accounts receivable | 8,966 | |||
| Related party receivables | 9,155 | |||
| Other current assets | 598 | |||
| Total current assets | 18,942 | |||
| Right-of-use asset | 0 | |||
| Total assets | 18,942 | |||
| Accounts payable and accrued expenses | 101,297 | |||
| Deferred revenues | 12,000 | |||
| Credit cards | 30,327 | |||
| Accrued interest | 22,095 | |||
| Related-party payables | 717,275 | |||
| Short-term loans (net of amortization of loan fees) | 111,721 | |||
| Sba loans current | 14,592 | |||
| Derivative liabilities | 0 | |||
| Lease liabilities | 0 | |||
| Convertible note | 6,363 | |||
| Total current liabilities | 1,015,670 | |||
| Sba loans | 249,500 | |||
| Total long-term liabilities | 249,500 | |||
| Total liabilities | 1,265,170 | |||
| Authorized 10,000,000 shares of preferred stock, without par value, of which 2,500,000 shares have been designated series a convertible preferred stock (2,500,000 shares outstanding at august 31, 2025, and may 31, 2025) and 2,000 shares have been designated series b preferred stock (2,000 shares outstanding at august 31, 2025, and may 31, 2025) | 0 | |||
| Common stock, without par value 20,000,000,000 shares authorized, of which 11,626,749,347 shares were issued and outstanding at august 31, 2025, and may 31, 2025 | 0 | |||
| Additional paid-in capital | 4,719,318 | |||
| Accumulated deficit | -5,965,546 | |||
| Total stockholders deficiency | -1,246,228 | |||
| Total liabilities and stockholders deficiency | 18,942 | |||
Cannabis Bioscience International Holdings, Inc. (CBIH)
Cannabis Bioscience International Holdings, Inc. (CBIH)